A comparison of blood spot vs

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Age at menarche: a predictor of diminished ovarian function?

Male contraception Fertility and Sterility

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study Carolyn Gibson, M.P.H., M.S., Karen Matthews,

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate Rebecca M. Fenichel,

The normal variabilities of the menstrual cycle

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Michael M. Alper, M.D. Fertility and Sterility

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

Hepatitis and reproduction

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women Ellen W. Freeman, Ph.D.,

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency Carrie.

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Oocyte cryopreservation

Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate Rebecca M. Fenichel,

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation Amanda.

Robert F. Casper, M.D. Fertility and Sterility

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist N. Rollene, M. Amols, S. Hudson,

Introduction Fertility and Sterility

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Effect of letrozole at 2. 5 mg or 5

One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above Sigal Klipstein, M.D., Meredith.

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Fertility and Sterility

MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D

Effectiveness of highly purified human menopausal gonadotropin vs

Relaxin has a role in establishing a renal response in pregnancy

Fertility and Sterility: an evaluation

The menopausal transition

Paolo Moghetti, M.D. Fertility and Sterility

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Association of endometriosis with body size and figure

Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.

Current evaluation of amenorrhea

A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child Xin Chen, M.D., M.Sc., Shi-ling Chen,

Fertility and Sterility

Inappropriate gonadotropin secretion in polycystic ovary syndrome

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Ahmed Badawy, M.D., Aboubakr.

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation Reshef.

When is clomiphene or gonadotropin intrauterine insemination futile

Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Presentation transcript:

A comparison of blood spot vs A comparison of blood spot vs. plasma analysis of gonadotropin and ovarian steroid hormone levels in reproductive-age women Alison Edelman, M.D., Richard Stouffer, Ph.D., David T. Zava, Ph.D., Jeffrey T. Jensen, M.D. Fertility and Sterility Volume 88, Issue 5, Pages 1404-1407 (November 2007) DOI: 10.1016/j.fertnstert.2006.12.016 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Single-visit study blood spot vs. plasma values with regression lines for (top left) E2 (in pg/mL, n = 66), (top right) P (in ng/mL, n = 59), (bottom right) FSH (in IU/mL, n = 90), and (bottom left) LH (in IU/mL, n = 90). Edelman. Blood spot vs. plasma analysis. Fertil Steril 2007. Fertility and Sterility 2007 88, 1404-1407DOI: (10.1016/j.fertnstert.2006.12.016) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Daily blood spot (left) vs. biweekly plasma (right) sampling (FSH, in IU/mL; LH, in IU/mL; P, in ng/mL; and E2, in pg/mL) for an entire menstrual cycle in one woman. Edelman. Blood spot vs. plasma analysis. Fertil Steril 2007. Fertility and Sterility 2007 88, 1404-1407DOI: (10.1016/j.fertnstert.2006.12.016) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions